BioSpace News Archive

CenExel Clinical Research (“CenExel”) announced that Stanford R. Plavin, MD, DABA, has joined Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence, as a principal investigator for clinical studies in several therapeutic categories including acute pain and vaccines

Cyxone (publ.) announced today that the company has filed for an extended patent protection of Rabeximod with the European Patent Office (EPO), that will be extended to other territories in due course

Valo Health, LLC (Valo), the technology company that is working to transform how drugs are discovered and developed, today announced the addition of two major hires: award-winning neurobiologist Virginie Buggia-Prevot, Ph.D., and leading data science expert, Andrea Rossi, Ph.D.

Lumen, the world’s first hand-held metabolic tracking device, together with Garmin® International, Inc., a unit of Garmin Ltd., have launched a Connect IQ Lumen App and Garmin Health API integration, allowing users to better understand the impact of fitness and nutrition decisions on their body in real time.

InterVenn Biosciences today announced that its proprietary liquid biopsy glycoproteomic research panel, Vista™, has demonstrated multi-indication performance in early cancer detection based on tests run in the company’s Bay Area laboratory. InterVenn, in collaboration with several large ph

MellingMedical has signed a distribution agreement that will improve Veterans Health Administration access to sophisticated surgical equipment designed to treat glaucoma, a condition that affects America’s veteran population at twice the rate of the population at large.

The U.S. Food and Drug Administration issued a draft guidance encouraging food manufacturers to voluntarily declare sesame in the ingredient list on food labels.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the organization’s Newborn Screening Pilot has been successfully screening babies born in New York State for Duchenne for over a year.

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 from 10:30 – 11:05 AM ET.

Edmonton-based companies MACH32 and Andau Medical bring to market an aerosol containment device to reduce risk of COVID-19 exposure for healthcare personnel and patients.